Company

About Company

NA Vaccine Institute develops various preventive and therapeutic
new drugs based on self-developed innovative technology.

After starting our business in February 2018, based on our understanding of the body's immune system and target diseases,
We aim to create a healthier and happier world through new drugs with better efficacy and improved side effects.

NA Vaccine Institute aims to become a global pharmaceutical company that delivers benefits and happiness to its members,
patients, shareholders, and society by continuously developing next-generation medicines to prevent and treat diseases.

NA Vaccine Institute is conducting
new drug development projects in the following five areas.

  • Development of anticancer
    treatments using various
    cancer antigens

  • Development of vaccines
    to prevent and treat chronic
    viral infections

  • Development of a cross-reaction
    prevention vaccine that can be
    applied to various mutant viruses

  • Development of combination
    treatment to improve
    immunotherapy drug potency

  • Development of tissue
    and organ regeneration
    treatments